Ceredex Value Advisors LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The firm purchased 236,353 shares of the company’s stock, valued at approximately $30,371,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Tocqueville Asset Management L.P. bought a new position in Merck KGaA in the 2nd quarter valued at approximately $57,546,000. August Group Capital Ltd bought a new stake in Merck KGaA during the 2nd quarter worth approximately $390,000. Great Lakes Advisors LLC bought a new stake in Merck KGaA during the 2nd quarter worth approximately $183,444,000. Bell & Brown Wealth Advisors LLC acquired a new position in Merck KGaA in the 2nd quarter valued at approximately $5,662,000. Finally, BOK Financial Private Wealth Inc. acquired a new position in Merck KGaA in the 2nd quarter valued at approximately $523,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $162.12 on Friday. The firm has a market cap of $20.95 billion, a PE ratio of 24.75 and a beta of 0.96. The firm’s fifty day moving average is $162.47 and its 200-day moving average is $148.35. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
